Follow us on Twitter: @GoAfricaNetwork
HealthSpot demonstrates the telehealth industry’s first integrated lab test with Samsung Electronics’ rapid lab testing device at NACDS Expo in Denver
DENVER – August 24, 2015 – 10:00 am MDT – NACDS -The Total Store Expo – Booth #419 – HealthSpot®, a pioneer in patient-centric and provider-driven healthcare technology, will unveil new point-of-care lab technology from Samsung that analyzes your blood while you wait with a drop of blood from a finger stick. Pending FDA approval, consumers will be able to obtain fast, easy and accurate blood tests for cholesterol, diabetes and liver tests, as well as other lab tests simultaneously, and get results in as little as 7 minutes.
HealthSpot has already transformed the retail clinic by adding a virtual healthcare provider visit and in the future will be able to automate and integrate lab visits. The HealthSpot technology will connect lab results not only with the doctor’s electronic medical record but with the consumer’s personal health record and with the consumer’s insurance benefit plan and billing.
Through HealthSpot’s telehealth platform and integrated biomedical equipment, medical providers can virtually examine a patient using equipment similar to that found in their doctor’s office. With the addition of point-of-care technology, clinicians will be able to get on-demand results to make decisions right at the point of care, providing health systems with efficiency and cost reduction while improving health outcomes.
At NACDS Expo, taking place August 22-25 in Denver, CO, HealthSpot will showcase Samsung’s latest medical innovation, the Samsung LABGEO PT10, a smart, compact clinical chemistry analyzer, which HealthSpot plans to deploy into its stations. Attendees can experience HealthSpot’s innovative, private kiosk that virtually connects patients to providers from local and national health systems. With the addition of Samsung’s blood analyzer, consumers will be able to get affordable and on-demand lab results in addition to access to healthcare providers, inside HealthSpot stations at convenient retail pharmacy locations. The Samsung LABGEO PT10 saves time for clinicians, improving efficiency and accuracy through automated and rapid testing in seven minutes. It also reduces wait times for consumers while requiring less blood from the patient for the analysis.
“Adding labs to HealthSpot significantly enhances our mission to transform healthcare for consumers and providers. We are transforming retail clinics into a true extension of the local medical community and widening the scope of services that can be offered via telehealth. The addition of blood analysis via Samsung’s smart point-of-care technology will allow providers to go one step further for virtual exams inside the HealthSpot station and serve patients better than ever before,” said HealthSpot CEO Steve Cashman. “We are helping consumerize healthcare-no more needles, no more wait and all at a lower cost. People like that.”
HealthSpot is already bringing the doctor’s office to consumers in retail pharmacies across Ohio. The HealthSpot station is a fully-enclosed, 40-square-foot kiosk enabled with proprietary cloud-based telemedicine software that allows patients to be seen and treated for a series of illnesses and conditions.
HealthSpot® is healthcare, reimagined. A pioneer in connected care, HealthSpot has built a comprehensive healthcare delivery platform that combines cloud-based software with the award-winning HealthSpot station, digital medical devices and mobile applications. HealthSpot’s platform radically transforms today’s healthcare system by enabling the delivery of quality, affordable medical care through a diverse professional care network for patients in efficient, convenient locations like pharmacies, hospitals, clinics, employer and community sites, universities and the home. For more information on HealthSpot, go to www.healthspot.net.
About the Samsung LABGEO PT10
The Samsung LABGEO PT10 is not FDA cleared and is not yet sold in the USA. The product is CE/IVD registered for international use and is currently sold outside the USA.